A new diabetic eye clinic for children in Western Australia, which opened last month, is part of the Lions Eye Institute’s first major clinical-research platform for children’s eye health.
Read more

A new diabetic eye clinic for children in Western Australia, which opened last month, is part of the Lions Eye Institute’s first major clinical-research platform for children’s eye health.
Read more
Nova Eye Medical has announced positive five-year follow-up data from a sub-study analysis of the multi-centre LEAD trial for its 2RT nano-pulse ophthalmic laser therapy. Read more
The Australian government spent more than $610 million on anti-VEGF treatments during the past year, with aflibercept (Eylea) leapfrogging a hepatitis C drug to become the costliest subsidised drug for the first time. Read more
A clinical trial is under way in Australia for a novel eye drop treatment for retinal vascular diseases that could replace the current approach involving serial intravitreal injections into the back of the eye. Read more
Researchers from the Centre for Eye Research Australia and University of Melbourne have developed a world-first survey to gather the views of Australians with inherited retinal diseases (IRDs) on potential gene therapies. Read more
An Australian researcher has contributed to a new study demonstrating that lower carbohydrate consumption can potentially put type 2 diabetes into remission. Read more
Swiss drug giant Roche is poised to pursue regulatory clearance for its new faricimab antibody for diabetic macular edema (DME) after it produced a similar effect to Eylea in twin clinical trials, but with half the dosing regimen in several patients. Read more
Despite vehement opposition from ophthalmologists, the MBS Taskforce has forged ahead with plans to cut the rebate for intravitreal injections and consider allowing nurses and optometrists to perform the procedure in its final report to the Federal Government. Read more
Novartis has announced positive findings from its the Phase 3 trial assessing the efficacy and safety of Beovu (brolucizumab) to treat diabetic macular edema (DME). Read more
Retina Australia has awarded a total of $160,000 in study grants to some of the biggest names in Australian retinal research. Read more